MORN2: A Potential Drug Target for Various Diseases (G729967)

Target Name: MORN2

NCBI ID: G729967

MORN2

MORN2: A Potential Drug Target for Various Diseases

MORN2 (also known as BLOCK27) is a protein that is expressed in various tissues throughout the body, including the brain, lungs, heart, and gastrointestinal tract. It is a member of the superfamily of RNA-protein hybrids, which are composed of a protein domain that is derived from RNA and a non-protein domain that is derived from a protein.

MORN2 is involved in a variety of cellular processes that are important for normal development, growth, and function. One of its well-known functions is its role in the development and progression of various diseases, including cancer.

Recent studies have identified MORN2 as a potential drug target for a variety of conditions, including cancer, neurodegenerative diseases, and autoimmune disorders. Its potential as a drug target is due to its unique structure, which allows it to interact with a variety of different molecules , as well as its involvement in a wide range of cellular processes that are important for human health and disease.

One of the key reasons for the potential of MORN2 as a drug target is its unique structure. MORN2 is a 21-kDa protein that consists of a 191-amino acid protein core and a 19-amino acid tail. The protein core is composed of a variety of different secondary structure elements, including a helix, a beta-sheet, and a loop. These structural elements give MORN2 its unique 3D structure, which allows it to interact with a wide range of different molecules.

MORN2 is involved in a variety of cellular processes that are important for normal development, growth, and function. One of its well-known functions is its role in the development and progression of various diseases, including cancer.

For example, studies have shown that MORN2 is involved in the development of various types of cancer, including breast, ovarian, and colorectal cancer. In addition, MORN2 has also been shown to be involved in the progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

Recent studies have identified MORN2 as a potential drug target for a variety of conditions, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and involvement in a wide range of cellular processes make it an attractive target for drug development.

In addition to its potential as a drug target, MORN2 has also been shown to be involved in a variety of other cellular processes that are important for human health and disease. For example, MORN2 is involved in the regulation of cell adhesion, which is important for the development and maintenance of tissues and organs. In addition, MORN2 is also involved in the regulation of cell signaling, which is important for the regulation of a wide range of cellular processes that are important for human health and disease.

In conclusion, MORN2 is a protein that is expressed in various tissues throughout the body and is involved in a variety of cellular processes that are important for normal development, growth, and function. Its unique structure and involvement in a wide range of cellular processes make it an attractive target for drug development. Studies have shown that MORN2 is involved in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, MORN2 is considered a potential drug target for a variety of conditions .

Protein Name: MORN Repeat Containing 2

Functions: Might have a role in spermatogenesis

The "MORN2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MORN2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets